Researchers develop selective inhibitors targeting BRCC36 for autoimmune disease therapy.
Elton Zeqiraj, F. Chandler, P. A. N. Reddy
― 5 min read
Cutting edge science explained simply
Researchers develop selective inhibitors targeting BRCC36 for autoimmune disease therapy.
Elton Zeqiraj, F. Chandler, P. A. N. Reddy
― 5 min read